interactivehwa.blogg.se

Application of defatting agents such as ethanol.

Acid concentration and soak time for demineralization.

Our aseptically processed fibers have some of the highest osteoinductive scores † on the market and this interconnected mesh of fibers enhances the osteoconductive potential of the product by providing a path for cellular infiltration.īecause allograft tissue processing, including demineralization, has evolved over time and is performed by numerous processors, it is important to recognize that not all demineralization processes are alike. Medtronic was the first to market with a fiber based DBM.

And a fiber technology proven to be osteoconductive in a preclinical outcomes study.

Validated process consistently produces an osteoinductive finished allograft.

Proven in prospective clinical studies.

Grafton™ DBM has been used in over 1.5 million surgeries.

Grafton™ DBM has over 25 years of clinical history.

The D-Min™ process ensures the viral inactivation and osteoinductivity of demineralized bone matrix. The proprietary demineralization process inactivates viruses while preserving the osteoinductive activity necessary for new bone formation.

Medtronic's processing facility, located in Eatontown, New Jersey, is accredited by the American Association of Tissue Banks (AATB), and is committed to providing quality and innovation in its various demineralized bone matrix tissue forms. Contraindications the presence of infection at the transplantation site is a contraindication for the use of this allograft. The product can also be used in bone grafting procedures in combination with autologous bone or other forms of allograft bone, or alone as a bone graft.

Grafton™ DBM demineralized bone fibers (DBF) can be used in orthopedic or reconstructive bone grafting procedures.